HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Short-term outcome of single-incision laparoscopic totally extra-peritoneal inguinal hernia repair.

Abstract
We performed single-incision laparoscopic surgery for totally extra-peritoneal (SILS-TEP) repair using a lightweight mesh fixed by absorbable tacks and without balloon dilation. Thirty-four patients (mean age, 66.5 years) underwent SILS-TEP repair in our hospital between September 2011 and April 2012; 30 patients had unilateral hernia and 4 had bilateral hernias. Mean operative time was 85.6 min for unilateral hernia and 137.7 min for bilateral hernias. All patients underwent successful SILS-TEP repair. Mean hospital stay was 3.4 days. Mean duration of follow-up was 7.1 months. Four seromas were observed, but no recurrences or major complications occurred. SILS-TEP is an economical and useful method for decreasing postoperative complications, such as neuralgia and recurrence, and it could be an attractive approach for inguinal hernia.
AuthorsMasaki Wakasugi, Hiroki Akamatsu, Masayuki Tori, Shigeyuki Ueshima, Takeshi Omori, Mitsuyoshi Tei, Toru Masuzawa, Toshirou Nishida
JournalAsian journal of endoscopic surgery (Asian J Endosc Surg) Vol. 6 Issue 2 Pg. 143-6 (May 2013) ISSN: 1758-5910 [Electronic] Japan
PMID23602002 (Publication Type: Evaluation Study, Journal Article)
Copyright© 2013 Japan Society for Endoscopic Surgery, Asia Endosurgery Task Force and Wiley Publishing Asia Pty Ltd.
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Follow-Up Studies
  • Hernia, Inguinal (surgery)
  • Herniorrhaphy (instrumentation, methods)
  • Humans
  • Laparoscopy (methods)
  • Male
  • Middle Aged
  • Prospective Studies
  • Surgical Mesh
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: